Decision/Conclude agreement
Proposed
泰格醫藥通過全資附屬香港泰格參與方達控股私有化及業務分拆
Tigermed will use its wholly owned Hong Kong subsidiary to take part in the privatization and business split of Frontage Holdings, a move UBS says may help it focus on core clinical CRO services.
Trajectories
Sign-in readers can mine up to three arcs for this record.
Actors and targets
Source
泰格醫藥宣布將通過全資附屬香港泰格,參與方達控股(01521)私有化及業務分拆。
Not established
- Announcement date
- Expected completion date
- Total transaction value
Extracted detail
Related decisions
Same kind only, ranked by embedding similarity to this record.